![Mark Sumeray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Sumeray
Director/Miembro de la Junta en
Metys Pharmaceuticals AG
.
Perfil
Mark Sumeray is currently a Director at Metys Pharmaceuticals AG.
Previously, he worked as the Chief Medical Officer at Aegerion Pharmaceuticals, Inc. from 2011 to 2016 and at Amryt Pharma Holdings Ltd. from 2016 to 2022.
Dr. Sumeray received his undergraduate and doctorate degrees from University College London.
Cargos activos de Mark Sumeray
| Empresas | Cargo | Inicio |
|---|---|---|
Metys Pharmaceuticals AG
 Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Mark Sumeray.
| Empresas | Cargo | Fin |
|---|---|---|
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Director Técnico/Científico/I+D | 27/06/2022 |
| AEGERION PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 28/01/2016 |
Formación de Mark Sumeray.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
33
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Metys Pharmaceuticals AG
Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
- Bolsa de valores
- Insiders
- Mark Sumeray
